94 related articles for article (PubMed ID: 24798153)
1. Comparison of two plasma urate assays in patients receiving vitamin C supplementation.
Sies CW; Florkowski CM; Frampton CM; O'Donnell JL; Chapman PT; Stamp LK
Pathology; 2014 Jun; 46(4):333-5. PubMed ID: 24798153
[TBL] [Abstract][Full Text] [Related]
2. Clinically insignificant effect of supplemental vitamin C on serum urate in patients with gout: a pilot randomized controlled trial.
Stamp LK; O'Donnell JL; Frampton C; Drake JM; Zhang M; Chapman PT
Arthritis Rheum; 2013 Jun; 65(6):1636-42. PubMed ID: 23681955
[TBL] [Abstract][Full Text] [Related]
3. Myeloperoxidase and oxidation of uric acid in gout: implications for the clinical consequences of hyperuricaemia.
Stamp LK; Turner R; Khalilova IS; Zhang M; Drake J; Forbes LV; Kettle AJ
Rheumatology (Oxford); 2014 Nov; 53(11):1958-65. PubMed ID: 24899662
[TBL] [Abstract][Full Text] [Related]
4. The effects of vitamin C supplementation on serum concentrations of uric acid: results of a randomized controlled trial.
Huang HY; Appel LJ; Choi MJ; Gelber AC; Charleston J; Norkus EP; Miller ER
Arthritis Rheum; 2005 Jun; 52(6):1843-7. PubMed ID: 15934094
[TBL] [Abstract][Full Text] [Related]
5. Relationship between serum urate and plasma oxypurinol in the management of gout: determination of minimum plasma oxypurinol concentration to achieve a target serum urate level.
Stamp LK; Barclay ML; O'Donnell JL; Zhang M; Drake J; Frampton C; Chapman PT
Clin Pharmacol Ther; 2011 Sep; 90(3):392-8. PubMed ID: 21796116
[TBL] [Abstract][Full Text] [Related]
6. Higher therapeutic plasma oxypurinol concentrations might be required for gouty patients with chronic kidney disease.
Panomvana D; Sripradit S; Angthararak S
J Clin Rheumatol; 2008 Feb; 14(1):6-11. PubMed ID: 18431090
[TBL] [Abstract][Full Text] [Related]
7. Long-term, low-dose, intravenous vitamin C leads to plasma calcium oxalate supersaturation in hemodialysis patients.
Canavese C; Petrarulo M; Massarenti P; Berutti S; Fenoglio R; Pauletto D; Lanfranco G; Bergamo D; Sandri L; Marangella M
Am J Kidney Dis; 2005 Mar; 45(3):540-9. PubMed ID: 15754276
[TBL] [Abstract][Full Text] [Related]
8. Vitamin C augments lymphocyte glutathione in subjects with ascorbate deficiency.
Lenton KJ; Sané AT; Therriault H; Cantin AM; Payette H; Wagner JR
Am J Clin Nutr; 2003 Jan; 77(1):189-95. PubMed ID: 12499341
[TBL] [Abstract][Full Text] [Related]
9. Further studies on the use of allopurinol to reduce plasma uric acid concentrations in the Red-tailed Hawk (Buteo jamaicensis) hyperuricaemic model.
Poffers J; Lumeij JT; Timmermans-Sprang EP; Redig PT
Avian Pathol; 2002 Dec; 31(6):567-72. PubMed ID: 12593739
[TBL] [Abstract][Full Text] [Related]
10. Febuxostat compared with allopurinol in patients with hyperuricemia and gout.
Becker MA; Schumacher HR; Wortmann RL; MacDonald PA; Eustace D; Palo WA; Streit J; Joseph-Ridge N
N Engl J Med; 2005 Dec; 353(23):2450-61. PubMed ID: 16339094
[TBL] [Abstract][Full Text] [Related]
11. Erythrocyte Ascorbate Is a Potential Indicator of Steady-State Plasma Ascorbate Concentrations in Healthy Non-Fasting Individuals.
Pullar JM; Dunham S; Dachs GU; Vissers MCM; Carr AC
Nutrients; 2020 Feb; 12(2):. PubMed ID: 32041092
[TBL] [Abstract][Full Text] [Related]
12. Does vitamin C supplementation influence the levels of circulating oxidized LDL, sICAM-1, sVCAM-1 and vWF-antigen in healthy male smokers?
Van Hoydonck PG; Schouten EG; Manuel-Y-Keenoy B; van Campenhout A; Hoppenbrouwers KP; Temme EH
Eur J Clin Nutr; 2004 Dec; 58(12):1587-93. PubMed ID: 15127090
[TBL] [Abstract][Full Text] [Related]
13. High-dose allopurinol improves endothelial function by profoundly reducing vascular oxidative stress and not by lowering uric acid.
George J; Carr E; Davies J; Belch JJ; Struthers A
Circulation; 2006 Dec; 114(23):2508-16. PubMed ID: 17130343
[TBL] [Abstract][Full Text] [Related]
14. Effect of ascorbate on serum lipids and urate metabolism during exhaustive training.
Yanai H; Morimoto M
Clin Sci (Lond); 2004 Jan; 106(1):107-9. PubMed ID: 12927020
[TBL] [Abstract][Full Text] [Related]
15. Furosemide increases plasma oxypurinol without lowering serum urate--a complex drug interaction: implications for clinical practice.
Stamp LK; Barclay ML; O'Donnell JL; Zhang M; Drake J; Frampton C; Chapman PT
Rheumatology (Oxford); 2012 Sep; 51(9):1670-6. PubMed ID: 22539486
[TBL] [Abstract][Full Text] [Related]
16. Vitamin C-lipid metabolites: uptake and retention and effect on plasma C-reactive protein and oxidized LDL levels in healthy volunteers.
Pancorbo D; Vazquez C; Fletcher MA
Med Sci Monit; 2008 Nov; 14(11):CR547-51. PubMed ID: 18971870
[TBL] [Abstract][Full Text] [Related]
17. A randomised controlled trial on the efficacy and tolerability with dose escalation of allopurinol 300-600 mg/day versus benzbromarone 100-200 mg/day in patients with gout.
Reinders MK; Haagsma C; Jansen TL; van Roon EN; Delsing J; van de Laar MA; Brouwers JR
Ann Rheum Dis; 2009 Jun; 68(6):892-7. PubMed ID: 18633127
[TBL] [Abstract][Full Text] [Related]
18. Hyperxanthinemia interferes with serum uric acid determinations by the uricase method.
Hande KR; Perini F; Putterman G; Elin R
Clin Chem; 1979 Aug; 25(8):1492-4. PubMed ID: 455692
[TBL] [Abstract][Full Text] [Related]
19. An audit of a therapeutic drug monitoring service for allopurinol therapy.
Kannangara DR; Ramasamy SN; Ray JE; Jones G; Graham GG; Williams KM; Day RO
Ther Drug Monit; 2013 Dec; 35(6):863-6. PubMed ID: 24263644
[TBL] [Abstract][Full Text] [Related]
20. Use of allopurinol in slowing the progression of renal disease through its ability to lower serum uric acid level.
Siu YP; Leung KT; Tong MK; Kwan TH
Am J Kidney Dis; 2006 Jan; 47(1):51-9. PubMed ID: 16377385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
